Whether CCL22 and/or CCL2 are significant Treg chemotactic factors in vivo is still a matter of contention (71, 72, 75); however, it is evident that other soluble factors within the glioma microenvironment also contribute to Treg chemotaxis, and these factors remain to be identified (72). The gene discussed is CCL22; the disease is central nervous system cancer.